-
ADAPTING AGENTIC LARGE LANGUAGE MODELS (ALLM) TRAINED IN SOLID TUMORS FOR SYSTEMATIC LITERATURE REVIEW (SLR) IN HEMATOLOGICAL MALIGNANCIES: VALIDATION IN MULTIPLE MYELOMA (MM) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Feb 25, 2026, 14:42 PM -
EARLY IDENTIFICATION AND MANAGEMENT OF POST-CARDIAC SURGERY COMPLICATIONS: IMPLICATIONS FOR CLINICAL PRACTICE, CARDIO-ONCOLOGY, AND HEALTH ECONOMICS
Feb 25, 2026, 14:42 PM -
WHEN TRIALS FALL SHORT: LEVERAGING REAL-WORLD EVIDENCE TO ADVANCE PRECISION THERAPIES
Feb 25, 2026, 14:42 PM -
ESTIMATING THE COST OF ORPHAN DRUG TREATMENT FROM THE PERSPECTIVE OF MEXICO'S PUBLIC SECTOR
Feb 25, 2026, 14:42 PM -
INTEGRATING RCT AND RWD FOR LONG-TERM NEONATAL OUTCOME EVALUATION: LESSONS FROM THE PRIME STUDY
Feb 25, 2026, 14:42 PM -
ARE EVIDENCE REVIEW REQUIREMENTS SIMILAR ACROSS HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES? A CROSS-SECTIONAL STUDY OF NICE, CDA, IQWIG AND EU JCA
Feb 25, 2026, 14:42 PM -
VARIATION IN AVERAGE INCREMENTAL COST-EFFECTIVENESS RATIOS ACROSS DISEASE GROUPS AND THE DISTRIBUTION OF RESEARCH AND DEVELOPMENT FUNDS
Feb 25, 2026, 14:42 PM -
CONTRACEPTION PREFERENCES OF WOMEN AND HEALTHCARE PROVIDERS: A DISCRETE CHOICE EXPERIMENT
Feb 25, 2026, 14:42 PM -
EVOLUTION OF AI VALUE IN CHINESE CLINICAL PRACTICE: A 2025 SURVEY AND CASE SERIES ON PHYSICIAN-PRIORITIZED APPLICATIONS
Feb 25, 2026, 14:42 PM -
COST-EFFECTIVENESS OF OBICETRAPIB OR FIXED-DOSE COMBINATION AS AN ADJUNCT TO MAXIMALLY TOLERATED STATINS
Feb 25, 2026, 14:42 PM -
CURATING FIT-FOR-PURPOSE GEOGRAPHIC REAL-WORLD DATA
Feb 25, 2026, 14:42 PM -
RETHINKING HEALTH ECONOMIC MODELS FOR OUTCOME-ALIGNED PAYMENTS: A FRAMEWORK FOR THE NEW 2026 CMS ACCESS MODEL
Feb 25, 2026, 14:42 PM -
MPACT OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS TO TREAT OBESITY ON NON-GLP-1 COSTS AMONG COMMERCIALLY INSURED MEMBERS WITHOUT DIABETES: A THREE-YEAR RETROSPECTIVE ANALYSIS
Feb 25, 2026, 14:42 PM -
INTEGRATING MACHINE LEARNING AND GENERATIVE AI ACROSS THE SYSTEMATIC REVIEW WORKFLOW - AN AI-ENHANCED SLR OF POST AMI CARDIOVASCULAR RISK AND CARDIOVASCULAR INFLAMMATION
Feb 25, 2026, 14:42 PM -
PREDICTORS OF 30-DAY HOSPITAL READMISSION AMONG PATIENTS WITH OPIOID USE DISORDER
Feb 25, 2026, 14:42 PM -
OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS
Feb 25, 2026, 14:42 PM -
GEOGRAPHIC MAPPING OF CANCER INCIDENCE IN DENMARK: IDENTIFYING POTENTIAL FOR DECENTRALIZED ONCOLOGY CARE IN LUNG CANCER CARE (HEATMAP-ONCO-LUNG)
Feb 25, 2026, 14:42 PM -
ENABLING HEALTH TECHNOLOGY ASSESSMENT (HTA) TA READINESS THROUGH REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEWS (REAL-SLR): A BREAST CANCER (BCA) CASE STUDY
Feb 25, 2026, 14:42 PM -
COMPARISON OF SAMPLING STRATEGIES TO ADDRESS SEVERE DATA IMBALANCE AND COMPUTATIONAL BENCHMARKING FOR TIME-TO-EVENT PREDICTIVE MODEL DEVELOPMENT ACROSS LOCAL AND HIGH-PERFORMANCE COMPUTING ENVIRONMENTS: PREDICTION OF ALCOHOL USE DISORDER AND OPIOID...
Feb 25, 2026, 14:42 PM -
DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS
Feb 25, 2026, 14:42 PM
